Skip to content

Coffee Against Obstipation in Intensive Care Treatment

Coffee Against Obstipation in Intensive Care Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01473966
Enrollment
120
Registered
2011-11-17
Start date
2011-11-30
Completion date
2014-06-30
Last updated
2011-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstipation

Brief summary

Coffee might stimulate bowel movement and thus overcome obstipation in intensive care unit (ICU) patients.

Detailed description

Critically ill patients requiring ventilator support frequently suffer from obstipation. We hypothesize that coffee, administered either orally or rectally, might stimulate bowel movement.

Interventions

DIETARY_SUPPLEMENTcoffee

patients will receive a cup of coffee at room temperature orally twice daily

DIETARY_SUPPLEMENTcoffee rectally

patients receive an enema of two cups of coffee at room temperature once daily

Sponsors

University Hospital Heidelberg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* admission to the medical intensive care unit of the Dept. of Gastroenterology at the university hospital heidelberg * requires ventilator support for an anticipated more than 72 hours * age older than 18 years

Exclusion criteria

* pregnancy * known allergy to coffee * mechanical ileus * presence of enterostoma

Design outcomes

Primary

MeasureTime frame
Bowel movement rateparticipants will be followed for the duration of hospital stay, an expected average of 5 weeks

Secondary

MeasureTime frame
time on mechanical ventilationparticipants will be followed for the duration of intensive care unit stay, an expected average of 3 weeks
time of stay on ICUparticipants will be followed for the duration of hospital stay, an expected average of 5 weeks
lengths of hospitalisationan average of 5 weeks of hospital stay is expected
in hospital mortalityparticipants will be followed for the duration of hospital stay, an expected average of 5 weeks
long term mortality6 months following discharge

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026